chrX-67545316-TGCAGCAGCA-T
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1
The NM_000044.6(AR):c.231_239delGCAGCAGCA(p.Gln78_Gln80del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0287 in 982,901 control chromosomes in the GnomAD database, including 418 homozygotes. There are 3,243 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.098   (  308   hom.,  647   hem.,  cov: 0) 
 Exomes 𝑓:  0.024   (  110   hom.  2596   hem.  ) 
Consequence
 AR
NM_000044.6 disruptive_inframe_deletion
NM_000044.6 disruptive_inframe_deletion
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  1.40  
Publications
10 publications found 
Genes affected
 AR  (HGNC:644):  (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017] 
AR Gene-Disease associations (from GenCC):
- androgen insensitivity syndromeInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
 - Kennedy diseaseInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
 - partial androgen insensitivity syndromeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
 - complete androgen insensitivity syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_000044.6
BP6
Variant X-67545316-TGCAGCAGCA-T is Benign according to our data. Variant chrX-67545316-TGCAGCAGCA-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 210223.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.105  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| AR | NM_000044.6  | c.231_239delGCAGCAGCA | p.Gln78_Gln80del | disruptive_inframe_deletion | Exon 1 of 8 | ENST00000374690.9 | NP_000035.2 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0976  AC: 6492AN: 66530Hom.:  308  Cov.: 0 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6492
AN: 
66530
Hom.: 
Cov.: 
0
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.0237  AC: 21760AN: 916384Hom.:  110   AF XY:  0.00938  AC XY: 2596AN XY: 276646 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
21760
AN: 
916384
Hom.: 
 AF XY: 
AC XY: 
2596
AN XY: 
276646
show subpopulations 
African (AFR) 
 AF: 
AC: 
746
AN: 
23351
American (AMR) 
 AF: 
AC: 
636
AN: 
25439
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
743
AN: 
15703
East Asian (EAS) 
 AF: 
AC: 
887
AN: 
27742
South Asian (SAS) 
 AF: 
AC: 
747
AN: 
42325
European-Finnish (FIN) 
 AF: 
AC: 
1634
AN: 
34883
Middle Eastern (MID) 
 AF: 
AC: 
100
AN: 
2511
European-Non Finnish (NFE) 
 AF: 
AC: 
14931
AN: 
705568
Other (OTH) 
 AF: 
AC: 
1336
AN: 
38862
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.455 
Heterozygous variant carriers
 0 
 1070 
 2140 
 3211 
 4281 
 5351 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 80 
 160 
 240 
 320 
 400 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0976  AC: 6493AN: 66517Hom.:  308  Cov.: 0 AF XY:  0.0788  AC XY: 647AN XY: 8215 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6493
AN: 
66517
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
647
AN XY: 
8215
show subpopulations 
African (AFR) 
 AF: 
AC: 
1796
AN: 
18771
American (AMR) 
 AF: 
AC: 
382
AN: 
5227
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
158
AN: 
1715
East Asian (EAS) 
 AF: 
AC: 
72
AN: 
1841
South Asian (SAS) 
 AF: 
AC: 
60
AN: 
900
European-Finnish (FIN) 
 AF: 
AC: 
133
AN: 
2019
Middle Eastern (MID) 
 AF: 
AC: 
18
AN: 
133
European-Non Finnish (NFE) 
 AF: 
AC: 
3744
AN: 
34658
Other (OTH) 
 AF: 
AC: 
77
AN: 
811
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 238 
 476 
 715 
 953 
 1191 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 64 
 128 
 192 
 256 
 320 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:7 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:3 
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Apr 08, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:3 
Nov 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 30, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Androgen resistance syndrome;C1839259:Kennedy disease    Benign:1 
Jul 24, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.